Ryan L. Kelly

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

Kelly D. Moynihan, Cary F. Opel, Gregory L. Szeto et al. · Nature Medicine · 2016 · 527 citations · Full text

Immune Evasion, Tumor Immunology, Cancer Immunosurveillance +15

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Zhi‐Wei Lai, Ryan L. Kelly, Thomas Winans et al. · The Lancet · 2018 · 390 citations

Rheumatology, Autoimmune Disease, Systemic Lupus Erythematosus Treatment +9

Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III Enzyme Forming ω-N-Monomethylated Arginine Residues

Cecilia I. Zurita‐Lopez, Troy E. Sandberg, Ryan L. Kelly et al. · Journal of Biological Chemistry · 2012 · 233 citations · Full text

PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145

Yanzhong Yang, Andrea Hadjikyriacou, Zheng Xia et al. · Nature Communications · 2015 · 222 citations · Full text

Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin

András Perl, Robert Hanczko, Zhi‐Wei Lai et al. · Metabolomics · 2015 · 181 citations · Full text